This Jamaican Scientist’s Marijuana-Based Anti-Cancer Drug Has Been Approved by the FDA

The U.S. Food and Drug Administration (FDA) recently granted orphan drug approval for Chrysoeriol, a cannabis-based drug used to treat acute myeloid leukaemia, which was developed by Jamaican scientist Dr. Henry Lowe.

Dr. Lowe founded Medicanja Ltd — described as “Jamaica’s first medical cannabis company” — in 2013. Its distinguished board of directors includes two former prime ministers and a former governor general.

The US Orphan Drug Act gives special status to a drug or biological product to treat a rare disease or condition upon the request of a sponsor.

Read More at GlobalVoices.org